基本信息
views: 195
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Skills and Expertise
Active Immunotherapy
Cancer Immunology
Tumor Immunology
Cancer Diagnostics
The Shukla lab is a highly translational group focused on antigen discovery and development of personalized immunotherapies. We develop computational approaches and harness state-of-the-art bulk and single-cell sequencing technologies and experimental assays to identify the full complement of tumor antigens in patient samples, and their cognate T-cell receptors. We are creating the next generation of personalized cancer vaccines designed to target antigens identified within each patient. These novel vaccination approaches will be tested in clinical trials across multiple tumor types.
We are building pipelines and machine learning models for integrated multi-omic analysis in order to elucidate mechanisms governing immunogenicity, immune escape and clinical outcomes to cancer immunotherapy. We are also establishing a comprehensive computational toolkit for characterization of highly polymorphic immune system-related genes which will significantly enable fundamental and translational research in tumor immunology.
Active Immunotherapy
Cancer Immunology
Tumor Immunology
Cancer Diagnostics
The Shukla lab is a highly translational group focused on antigen discovery and development of personalized immunotherapies. We develop computational approaches and harness state-of-the-art bulk and single-cell sequencing technologies and experimental assays to identify the full complement of tumor antigens in patient samples, and their cognate T-cell receptors. We are creating the next generation of personalized cancer vaccines designed to target antigens identified within each patient. These novel vaccination approaches will be tested in clinical trials across multiple tumor types.
We are building pipelines and machine learning models for integrated multi-omic analysis in order to elucidate mechanisms governing immunogenicity, immune escape and clinical outcomes to cancer immunotherapy. We are also establishing a comprehensive computational toolkit for characterization of highly polymorphic immune system-related genes which will significantly enable fundamental and translational research in tumor immunology.
Research Interests
Papers共 148 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
crossref(2023)
Nature communicationsno. 1 (2023): 346-16
Dustin McCurry,Zhongqi Ge, Jaehyun Lee, Pranaya Raparla,Thomas Koehnke, Rishi Pasumarthi,Xiaohong Leng,Oren Pasvolsky,Vinhkhang Nguyen,Katie Maurer,Shuqiang Li,Kenneth J. Livak,
BLOOD (2023): 364
Sachet A. Shukla, Tejas Jammihal, R.M. Saliby,Chris Labaki, Hanna Soulati, Juan Gallegos, Alberto Cuesta,Dustin McCurry,Yu Chen,Valisha Shah, Deepak Poduval,Talal El Zarif,
Research Square (Research Square) (2023)
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)
ONCOLOGISTno. Supplement_1 (2023): S7-S8
crossref(2023)
crossref(2023)
Hongyi Zhang,Longchao Liu,Jian Zhang, Jiahui Chen, Jianfeng Ye,Sachet Shukla, Jian Qiao,Xiaowei Zhan,Hao Chen,Catherine J. Wu,Yang-Xin Fu,Bo Li
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn